Several APP transgenic mouse models, such as TgCRND8 and 3xTg-AD (which contains mutant human tau P301L), had increased hippocampal synaptic plasticity, which was associated with episodic memory deficits [58, 59]. Here, MAPT is linked to Alzheimer disease.